Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer

Final draft guidance

Final draft guidance (PDF 317 KB)

Committee papers (PDF 2.14 MB)

Public committee slides (PDF 723 KB)

Draft guidance

Draft guidance (online commenting)

Draft guidance (downloadable version) (PDF 322 KB)

Committee papers (PDF 8.21 MB)

Public committee slides (PDF 1.75 MB)

Final scope (PDF 182 KB)

Final stakeholder list (PDF 176 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 234 KB)

Final scope (PDF 196 KB)

Final stakeholder list (PDF 190 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 231 KB)

Draft matrix post referral (PDF 187 KB)